Market Overview:
The global atopic dermatitis treatment market is expected to grow from USD 3.5 billion in 2018 to USD 6.8 billion by 2030, at a CAGR of 8.7% during the forecast period. The growth of this market can be attributed to the increasing prevalence of atopic dermatitis, rising awareness about available treatments, and growing demand for combination therapies. Based on type, the global atopic dermatitis treatment market is segmented into topical therapies, oral therapies, and injectable therapies. The topical therapy segment is expected to account for the largest share of the global atopic dermatitis treatment market in 2018.
Product Definition:
Atopic dermatitis is a type of skin inflammation that usually affects the skin on the face, neck, inside of the elbows and behind the knees. It is a long-term (chronic) condition.
-Wet dressings or compresses to cool and soothe inflamed skin. -Moisturizers to help keep your skin hydrated. -Topical corticosteroids to reduce inflammation. -Antihistamines if you are itchy.
Topical:
Topical corticosteroids are the most commonly used medications for atopic dermatitis. They are usually administered in the form of cream, ointment or lotion and can be applied directly to the skin. Topical corticosteroids have a wide range of side effects such as scalp irritation, acne, diabetes and cataract which makes it difficult to use them topically for long term treatment.
Oral:
Oral is a form of medication that is taken in the mouth. The drug may be administered as a tablet, capsule or liquid and it is absorbed by the body through the gastrointestinal tract. Some drugs are also formulated for direct application to affected areas.
Application Insights:
The others application segment held the largest share of more than 60.0% in 2017. This segment includes home healthcare and hospital pharmacies. Hospital pharmacies are expected to be the fastest-growing segment, with a CAGR of XX% from 2018 to 2030 owing to an increase in atopic dermatitis treatment needs due to rising awareness among patients as well as healthcare professionals regarding available treatments for AD.
Hospital pharmacist plays an important role in dispensing medicines that cure, palliate or prevent Atopic Dermatitis (AD). Pharmacists provide information related to medicines including their uses, side effects and effectiveness against different types of AD according these factors; type of pharmacy (hospital or non-hospital), location (retail or online) and other factors such as availability of products through online channels at cheaper prices coupled with easy payment options is expected to drive growth over the forecast period for this application sector globally.
Regional Analysis:
North America dominated the global atopic dermatitis treatment market in 2017. The presence of well-established healthcare facilities, favorable reimbursement policies, and increasing awareness levels among patients are some of the major factors responsible for its large share. Moreover, rising prevalence of atopic dermatitis in this region is also expected to drive growth during the forecast period. According to a study conducted by National Institute of Health (NIH), around 20% to 40% children between 6 months and 17 years old suffered from moderate or severe forms of atopic dermatitis in U.S., which was later found to be genetic’s prone condition called as Atopica Prone Dermatitis (APD).
Asia Pacific is expected to witness lucrative growth over the forecast period owing to high unmet clinical needs coupled with rapidly improving healthcare infrastructure especially in developing countries such as India and China.
Growth Factors:
- Increasing prevalence of atopic dermatitis
- Growing awareness about atopic dermatitis and its treatment options
- Rising demand for better and more effective atopic dermatitis treatments
- Technological advancements in the field of atopic dermatitis treatment 5. Growing number of clinical studies on new atopic dermatitis treatments
Scope Of The Report
Report Attributes
Report Details
Report Title
Atopic Dermatitis Treatment Market Research Report
By Type
Topical, Oral, Injectable
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others
By Companies
Sanofi, Allergan, Novartis, Bristol Myers Squibb, Bayer, Meda Pharmaceuticals, Anacor Pharmaceutical, Pfizer, Astellas Pharma, Regeneron Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
140
Number of Tables & Figures
98
Customization Available
Yes, the report can be customized as per your need.
Global Atopic Dermatitis Treatment Market Report Segments:
The global Atopic Dermatitis Treatment market is segmented on the basis of:
Types
Topical, Oral, Injectable
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Allergan
- Novartis
- Bristol Myers Squibb
- Bayer
- Meda Pharmaceuticals
- Anacor Pharmaceutical
- Pfizer
- Astellas Pharma
- Regeneron Pharmaceuticals
Highlights of The Atopic Dermatitis Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Topical
- Oral
- Injectable
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Atopic Dermatitis Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no one-size-fits-all answer to this question, as the best treatment for atopic dermatitis will vary depending on the individual's symptoms and overall health. However, some common treatments for atopic dermatitis include topical medications such as corticosteroids or antihistamines, dietary modifications such as avoiding foods that are known to trigger flareups, and physical therapy or massage therapy.
Some of the major players in the atopic dermatitis treatment market are Sanofi, Allergan, Novartis, Bristol Myers Squibb, Bayer, Meda Pharmaceuticals, Anacor Pharmaceutical, Pfizer, Astellas Pharma, Regeneron Pharmaceuticals.
The atopic dermatitis treatment market is expected to register a CAGR of 8.7%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Atopic Dermatitis Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Atopic Dermatitis Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Atopic Dermatitis Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Atopic Dermatitis Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Atopic Dermatitis Treatment Market Size & Forecast, 2020-2028
4.5.1 Atopic Dermatitis Treatment Market Size and Y-o-Y Growth
4.5.2 Atopic Dermatitis Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Topical
5.2.2 Oral
5.2.3 Injectable
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Atopic Dermatitis Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Atopic Dermatitis Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Topical
9.6.2 Oral
9.6.3 Injectable
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Topical
10.6.2 Oral
10.6.3 Injectable
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Topical
11.6.2 Oral
11.6.3 Injectable
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Topical
12.6.2 Oral
12.6.3 Injectable
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Topical
13.6.2 Oral
13.6.3 Injectable
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Atopic Dermatitis Treatment Market: Competitive Dashboard
14.2 Global Atopic Dermatitis Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi
14.3.2 Allergan
14.3.3 Novartis
14.3.4 Bristol Myers Squibb
14.3.5 Bayer
14.3.6 Meda Pharmaceuticals
14.3.7 Anacor Pharmaceutical
14.3.8 Pfizer
14.3.9 Astellas Pharma
14.3.10 Regeneron Pharmaceuticals
